Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma

NCT06112522 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Cell Carcinoma

Interventions

DRUG: Tirbanibulin

Sponsor

Centre Hospitalier Universitaire de Nice